Top news of the week: 11.07.2022.
RT @matthewherper: 41 books and podcasts on health and science to check out this summer https://t.co/nwykUy8vQ0
Open
The 41 best books and podcasts on health and science to check out this summer
The STAT summer book/podcast list is back: Check out recommendations from @michaelpollan, @doctorsoumya, @mclemoremr, @drpennyheaton, STAT readers and staff, and more!
"We continue to believe Beam has additional levers of upside that could drive the company's long-term value" - Wedbush reports on an Amended Agreement to Benefit Two Biotech Firms: https://t.co/areDpAQFtb
$BEAM $VERV #leukemia #geneediting #biotech #stocks @BeamTx @VerveTx
OpenAmended Agreement to Benefit Two Biotech Firms Research Report
In the new arrangement each of the companies grants the other an exclusive license, noted a Wedbush report.
@Genmab and partner AbbVie plan to file biologics license application with the FDA for subcutaneous epcoritamab for relapsed and refractory large B cell lymphoma.
Strong Data Suggest #FDA Will Approve New #Lymphoma Drug: https://t.co/Ft5o9hIa9y
#Biopharma #Stocks #Investments https://t.co/UvJXDqqlWQ
OpenStrong Data Suggest FDA Will Approve New Lymphoma Drug Research Report
A green light is expected for the treatment after its developers file a BLA for it, planned for H2/22, noted an H.C. Wainwright & Co. report.
Inhalable COVID-19 vaccine shows promise in rodent model https://t.co/ut1Qr9tU39 #sciencenews
OpenInhalable COVID-19 vaccine shows promise in rodent model
Researchers have created an inhalable COVID-19 vaccine that is shelf stable at room temperature for up to three months, targets the lungs specifically and effectively, and allows for ...